We are live on ! Find out more
ICCC icon

ImmuCell
ICCC

19 hedge funds and large institutions have $5.31M invested in ImmuCell in 2018 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.24% less ownership

Funds ownership: 14.02% → 13.78% (-0.24%)

10% less funds holding

Funds holding: 21 → 19 (-2)

17% less capital invested

Capital invested by funds: $6.4M → $5.31M (-$1.09M)

20% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 5

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
19
Holders Change
-2
Holders Change %
-9.52%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
4
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$49K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$25.3K
3
Morgan Stanley
Morgan Stanley
New York
+$7.73K
4
TRCT
Tower Research Capital (TRC)
New York
+$1.91K

Top Sellers

Rank Fund Capital Flow
1
Northern Trust
Northern Trust
Illinois
-$87K
2
Deutsche Bank
Deutsche Bank
Germany
-$37K
3
Renaissance Technologies
Renaissance Technologies
New York
-$33.2K
4
EFS
Essex Financial Services
Connecticut
-$21.5K
5
UBS Group
UBS Group
Switzerland
-$1.93K
Name Holding Trade Value Shares
Change 		Change in
Stake
HA
1
Heartland Advisors
Wisconsin
$1.41M – – –
PCM
2
Perritt Capital Management
Illinois
$1.09M – – –
Renaissance Technologies
3
Renaissance Technologies
New York
$647K -$33.2K -4,294 -4%
ISL
4
Ingalls & Snyder LLC
New York
$645K – – –
Vanguard Group
5
Vanguard Group
Pennsylvania
$531K +$49K +6,344 +9%
SRC
6
Shufro Rose & Co
New York
$357K -$935 -121 -0.2%
EFS
7
Essex Financial Services
Connecticut
$148K -$21.5K -2,776 -12%
Susquehanna International Group
8
Susquehanna International Group
Pennsylvania
$116K +$25.3K +3,270 +25%
MA
9
Minerva Advisors
Pennsylvania
$100K – – –
RC
10
RBF Capital
California
$92K – – –
Morgan Stanley
11
Morgan Stanley
New York
$90K +$7.73K +1,000 +9%
UBS Group
12
UBS Group
Switzerland
$28K -$1.93K -250 -6%
Bank of America
13
Bank of America
North Carolina
$21K -$982 -127 -4%
FHA
14
Flagship Harbor Advisors
Massachusetts
$21K – – –
BlackRock
15
BlackRock
New York
$10K – – –
Citigroup
16
Citigroup
New York
$6K – – –
TRCT
17
Tower Research Capital (TRC)
New York
$4K +$1.91K +247 +84%
Northern Trust
18
Northern Trust
Illinois
– -$87K -10,443 Closed
Deutsche Bank
19
Deutsche Bank
Germany
– -$37K -4,500 Closed

ICCC Hedge Fund Activity: Q4 2018 in Review

19 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q4 2018, worth a combined $5.31M — down 17% from $6.4M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of ICCC and 0 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 4 added.

The largest buyer was Vanguard Group, adding an estimated $49K. The largest seller was Northern Trust, exiting entirely with an estimated $87K sold.

  • 19 institutional investors held ImmuCell (ICCC) as of Q4 2018, down from 21 in Q3 2018.
  • Funds reported $5.31M of ImmuCell stock for Q4 2018, down 17% quarter-over-quarter.
  • 0 funds opened new ImmuCell positions in Q4 2018 and 2 closed out, a net change of -2 holders.
  • The largest ImmuCell buyer in Q4 2018 was Vanguard Group, an estimated $49K added.
  • The largest ImmuCell seller in Q4 2018 was Northern Trust, an estimated $87K sold.

Based on aggregated 13F filings for Q4 2018.